124 related articles for article (PubMed ID: 32861707)
1. ADAM28: Another ambivalent protease in cancer.
Hubeau C; Rocks N; Cataldo D
Cancer Lett; 2020 Dec; 494():18-26. PubMed ID: 32861707
[TBL] [Abstract][Full Text] [Related]
2. Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.
Mochizuki S; Soejima K; Shimoda M; Abe H; Sasaki A; Okano HJ; Okano H; Okada Y
J Natl Cancer Inst; 2012 Jun; 104(12):906-22. PubMed ID: 22636800
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.
Rudnicka C; Mochizuki S; Okada Y; McLaughlin C; Leedman PJ; Stuart L; Epis M; Hoyne G; Boulos S; Johnson L; Schlaich M; Matthews V
Medicine (Baltimore); 2016 Oct; 95(40):e5085. PubMed ID: 27749584
[TBL] [Abstract][Full Text] [Related]
4. [Research advances on ADAM28 expression and ADAM28-mediated tumor metastasis].
Zhu XL; Wang QM; Feng FE; Zheng XL; Zhang XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1142-7. PubMed ID: 25130845
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
Okada Y
Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
[TBL] [Abstract][Full Text] [Related]
6. ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand Factor-induced apoptosis of gastric cancer cells.
Yin Q; Gu J; Qi Y; Lu Y; Yang L; Liu J; Liang X
Eur J Pharmacol; 2021 May; 898():173994. PubMed ID: 33675784
[TBL] [Abstract][Full Text] [Related]
7. ADAM28 as a target for human cancers.
Mochizuki S; Okada Y
Curr Pharm Des; 2009; 15(20):2349-58. PubMed ID: 19601836
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment-derived ADAM28 prevents cancer dissemination.
Gérard C; Hubeau C; Carnet O; Bellefroid M; Sounni NE; Blacher S; Bendavid G; Moser M; Fässler R; Noel A; Cataldo D; Rocks N
Oncotarget; 2018 Dec; 9(98):37185-37199. PubMed ID: 30647853
[TBL] [Abstract][Full Text] [Related]
9. Src plays a key role in ADAM28 expression in v-src-transformed epithelial cells and human carcinoma cells.
Abe H; Mochizuki S; Ohara K; Ueno M; Ochiai H; Kitagawa Y; Hino O; Sato H; Okada Y
Am J Pathol; 2013 Nov; 183(5):1667-1678. PubMed ID: 24007880
[TBL] [Abstract][Full Text] [Related]
10. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.
Mitsui Y; Mochizuki S; Kodama T; Shimoda M; Ohtsuka T; Shiomi T; Chijiiwa M; Ikeda T; Kitajima M; Okada Y
Cancer Res; 2006 Oct; 66(20):9913-20. PubMed ID: 17047053
[TBL] [Abstract][Full Text] [Related]
11. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
Ohtsuka T; Shiomi T; Shimoda M; Kodama T; Amour A; Murphy G; Ohuchi E; Kobayashi K; Okada Y
Int J Cancer; 2006 Jan; 118(2):263-73. PubMed ID: 16052521
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor is a substrate of ADAM28.
Mochizuki S; Tanaka R; Shimoda M; Onuma J; Fujii Y; Jinno H; Okada Y
Biochem Biophys Res Commun; 2010 Nov; 402(4):651-7. PubMed ID: 20971063
[TBL] [Abstract][Full Text] [Related]
13. ADAM28 is a serological and histochemical marker for non-small-cell lung cancers.
Kuroda H; Mochizuki S; Shimoda M; Chijiiwa M; Kamiya K; Izumi Y; Watanabe M; Horinouchi H; Kawamura M; Kobayashi K; Okada Y
Int J Cancer; 2010 Oct; 127(8):1844-56. PubMed ID: 20112342
[TBL] [Abstract][Full Text] [Related]
14. ADAM28 localizes to HLA-G
De Luca LC; Le HT; Mara DL; Beristain AG
Placenta; 2017 Jul; 55():71-80. PubMed ID: 28623976
[TBL] [Abstract][Full Text] [Related]
15. Modulation of integrin α4β1 by ADAM28 promotes lymphocyte adhesion and transendothelial migration.
McGinn OJ; English WR; Roberts S; Ager A; Newham P; Murphy G
Cell Biol Int; 2011 Oct; 35(10):1043-53. PubMed ID: 21332445
[TBL] [Abstract][Full Text] [Related]
16. ADAMs in cancer cell proliferation and progression.
Mochizuki S; Okada Y
Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
[TBL] [Abstract][Full Text] [Related]
17. Selective Inhibition of ADAM28 Suppresses Lung Carcinoma Cell Growth and Metastasis.
Mochizuki S; Shimoda M; Abe H; Miyamae Y; Kuramoto J; Aramaki-Hattori N; Ishii K; Ueno H; Miyakoshi A; Kojoh K; Okada Y
Mol Cancer Ther; 2018 Nov; 17(11):2427-2438. PubMed ID: 30190423
[TBL] [Abstract][Full Text] [Related]
18. ADAM28 is expressed by epithelial cells in human normal tissues and protects from C1q-induced cell death.
Miyamae Y; Mochizuki S; Shimoda M; Ohara K; Abe H; Yamashita S; Kazuno S; Ohtsuka T; Ochiai H; Kitagawa Y; Okada Y
FEBS J; 2016 May; 283(9):1574-94. PubMed ID: 26918856
[TBL] [Abstract][Full Text] [Related]
19. ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation.
Zhang JM; Wang CC; Zhang GC; Jiang Q; Yang SM; Fu HX; Wang QM; Zhu XL; Zhu HH; Jiang H; Wang Y; Lv M; Lu J; Chen H; Han W; Chang YJ; Kong Y; Xu LP; Liu KY; Huang XJ; Zhang XH
Cancer Lett; 2019 Feb; 442():193-201. PubMed ID: 30429106
[TBL] [Abstract][Full Text] [Related]
20. [The construction of ADAM28 eukaryotic expression plasmid and expression after transfected into HDFC].
Zhao Z; Huang ZN; Xu JM
Shanghai Kou Qiang Yi Xue; 2007 Aug; 16(4):404-9. PubMed ID: 17924028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
